Genetic testing error raises health concerns for breast cancer screening

Israel’s Health Ministry reported a potential defect in Gamidor’s BRCA1 genetic testing kits affecting approximately 100 of over 90,000 samples, raising concerns about false negative results for breast cancer risk assessment. The ministry has confirmed the fault has been corrected and no public action is required at this time.

Sources: Israel Hayom

More Headlines

View All ->

Stay Informed.

Receive the latest Israel briefings every day directly to your inbox.

No spam. Unsubscribe anytime.